Vontobel Holding Ltd. Madrigal Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

  • $27.3 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jun 03, 2024
BUY
$203.88 - $312.0 $222,433 - $340,392
1,091 New
1,091 $252,000
Q2 2023

Jul 24, 2023
BUY
$203.88 - $312.0 $222,433 - $340,392
1,091 New
1,091 $252,000
Q4 2022

Feb 14, 2023
BUY
$58.39 - $296.54 $47,237 - $239,900
809 New
809 $234,000

Others Institutions Holding MDGL

# of Institutions
337
Shares Held
22.3M
Call Options Held
960K
Put Options Held
940K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.61B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email